BRPI1010693A2 - métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeito - Google Patents
métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeitoInfo
- Publication number
- BRPI1010693A2 BRPI1010693A2 BRPI1010693A BRPI1010693A BRPI1010693A2 BR PI1010693 A2 BRPI1010693 A2 BR PI1010693A2 BR PI1010693 A BRPI1010693 A BR PI1010693A BR PI1010693 A BRPI1010693 A BR PI1010693A BR PI1010693 A2 BRPI1010693 A2 BR PI1010693A2
- Authority
- BR
- Brazil
- Prior art keywords
- subject
- computer
- scoring
- kits
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
Abstract
métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeito são proporcionados marcadores e métodos úteis para avaliar doença da artéria coronária em um sujeito, juntamente com kits para medir a sua expressão. são também proporcionados modelos preditivos, com base nos marcadores, assim como também modalidades de sistemas de computador e de software dos modelos para pontuação e opcionalmente classificação de amostras.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18720309P | 2009-06-15 | 2009-06-15 | |
US24519009P | 2009-09-23 | 2009-09-23 | |
PCT/US2010/038712 WO2010148017A1 (en) | 2009-06-15 | 2010-06-15 | Determination of coronary artery disease risk. |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1010693A2 true BRPI1010693A2 (pt) | 2019-07-16 |
Family
ID=43356727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1010693A BRPI1010693A2 (pt) | 2009-06-15 | 2010-06-15 | métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeito |
Country Status (13)
Country | Link |
---|---|
US (3) | US9122777B2 (pt) |
EP (1) | EP2443449B1 (pt) |
JP (1) | JP2012529914A (pt) |
KR (1) | KR20120046171A (pt) |
CN (1) | CN102803951A (pt) |
AU (1) | AU2010260152A1 (pt) |
BR (1) | BRPI1010693A2 (pt) |
CA (1) | CA2765145A1 (pt) |
DK (1) | DK2443449T3 (pt) |
EA (1) | EA201270020A1 (pt) |
IL (1) | IL216875A0 (pt) |
SG (2) | SG176692A1 (pt) |
WO (1) | WO2010148017A1 (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG176692A1 (en) | 2009-06-15 | 2012-01-30 | Cardiodx Inc | Determination of coronary artery disease risk. |
MX355020B (es) | 2010-07-09 | 2018-04-02 | Somalogic Inc | Biomarcadores de cancer de pulmon y usos de los mismos. |
CN106198980B (zh) | 2010-08-13 | 2018-09-07 | 私募蛋白质体公司 | 胰腺癌生物标记及其用途 |
WO2012094366A1 (en) * | 2011-01-06 | 2012-07-12 | Cardiodx, Inc. | Circulating mirnas as biomarkers for coronary artery disease |
SG11201400904SA (en) * | 2011-09-30 | 2014-04-28 | Somalogic Inc | Cardiovascular risk event prediction and uses thereof |
CN104101715A (zh) * | 2014-07-15 | 2014-10-15 | 重庆医科大学附属儿童医院 | 检测dock8蛋白的试剂盒及非诊断目的检测dock8蛋白的方法 |
WO2016076899A1 (en) | 2014-11-14 | 2016-05-19 | Medidata Solutions, Inc. | System and method for determining subject conditions in mobile health clinical trials |
ES2963268T3 (es) * | 2015-07-31 | 2024-03-26 | Immunewalk Therapeutics Inc | Proteína 2 que contiene el dominio de esperma móvil e inflamación |
CA2991868A1 (en) | 2015-07-31 | 2017-02-09 | Vascular Biogenics Ltd. | Motile sperm domain containing protein 2 and cancer |
EP3344986A4 (en) * | 2015-09-01 | 2019-02-06 | CardioDx, Inc. | MARKERS OF CORONARY DISEASE AND USES THEREOF |
US11056218B2 (en) | 2016-05-31 | 2021-07-06 | International Business Machines Corporation | Identifying personalized time-varying predictive patterns of risk factors |
CN106327476A (zh) * | 2016-08-25 | 2017-01-11 | 于洋 | 一种ct图像处理方法及装置 |
CA3035557A1 (en) | 2016-09-01 | 2018-03-08 | The George Washington University | Blood rna biomarkers of coronary artery disease |
US10832815B2 (en) | 2017-05-18 | 2020-11-10 | International Business Machines Corporation | Medical side effects tracking |
CN107238712B (zh) * | 2017-06-05 | 2018-12-28 | 中国人民解放军沈阳军区总医院 | 血浆s100a12在st段抬高型心肌梗死预后中的应用 |
CN107271681A (zh) * | 2017-06-05 | 2017-10-20 | 中国人民解放军沈阳军区总医院 | 血浆s100a12在st段抬高型心肌梗死早期诊断中的应用 |
CN107292128A (zh) * | 2017-06-27 | 2017-10-24 | 湖南农业大学 | 一种配对互作基因检测方法及预测模型 |
CN107937521B (zh) * | 2017-11-19 | 2019-01-04 | 武汉迈特维尔生物科技有限公司 | 用于检测肾上腺皮质癌的试剂盒 |
CN111354464A (zh) * | 2018-12-24 | 2020-06-30 | 深圳先进技术研究院 | Cad预测模型建立方法、装置以及电子设备 |
CN111789949A (zh) * | 2019-04-08 | 2020-10-20 | 北京昱嘉科技集团有限公司 | 基于特异性趋化因子受体的阿尔兹海默病治疗靶点 |
RU2740246C1 (ru) * | 2020-03-20 | 2021-01-12 | Жанна Залкуфовна Отарова | Способ определения высокого риска атеросклероза сонных артерий при ревматоидном артрите |
IL301202A (en) | 2020-09-10 | 2023-05-01 | Vascular Biogenics Ltd | Antibodies against MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 and methods of using them |
CN112835316B (zh) * | 2021-01-06 | 2022-04-19 | 重庆医科大学 | 新生儿败血症休克预测系统及监控设备 |
CN113295874B (zh) * | 2021-05-25 | 2022-03-04 | 广东源心再生医学有限公司 | 一种用于瓣膜性心脏病辅助诊断的新型标志物、辅助诊断的产品 |
CN113667740B (zh) * | 2021-08-27 | 2023-12-26 | 河北医科大学第二医院 | 分子标志物组合在诊断心血管疾病中的应用 |
CN113667739B (zh) * | 2021-08-27 | 2023-12-26 | 河北医科大学第二医院 | 冠状动脉疾病的诊断标志物组合 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020151479A1 (en) * | 2000-01-31 | 2002-10-17 | Rosen Craig A. | Nucleic acids, proteins, and antibodies |
US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
US20030099958A1 (en) * | 2001-09-05 | 2003-05-29 | Vitivity, Inc. | Diagnosis and treatment of vascular disease |
US20050032066A1 (en) * | 2003-08-04 | 2005-02-10 | Heng Chew Kiat | Method for assessing risk of diseases with multiple contributing factors |
WO2005040422A2 (en) * | 2003-10-16 | 2005-05-06 | Novartis Ag | Differentially expressed genes related to coronary artery disease |
US20070238124A1 (en) * | 2003-10-16 | 2007-10-11 | Chibout Salah D | Differentially expressed genes related to coronary artery disease |
US20060099608A1 (en) * | 2004-03-29 | 2006-05-11 | Medstar Research Institute | Methods of diagnosing cardiovascular disease |
AU2006259583A1 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
US20070015170A1 (en) * | 2005-07-12 | 2007-01-18 | Oy Jurilab Ltd | Method and kit for detecting a risk of coronary heart disease |
US20100035963A1 (en) * | 2005-09-09 | 2010-02-11 | Ayelet Chajut | Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease |
EP2924440A3 (en) * | 2006-06-07 | 2016-03-09 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
US20080300797A1 (en) * | 2006-12-22 | 2008-12-04 | Aviir, Inc. | Two biomarkers for diagnosis and monitoring of atherosclerotic cardiovascular disease |
MX2009008878A (es) | 2007-02-21 | 2009-08-28 | Decode Genetics Ehf | Variantes de susceptibilidad genetica asociada con la enfermedad cardiovascular. |
US7695916B2 (en) * | 2007-03-22 | 2010-04-13 | Celera Corporation | Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof |
EP2155907B1 (en) | 2007-04-30 | 2015-05-27 | Decode Genetics EHF | Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction |
US20110184712A1 (en) * | 2007-10-11 | 2011-07-28 | Cardiodx, Inc. | Predictive models and methods for diagnosing and assessing coronary artery disease |
WO2010038104A1 (en) * | 2008-10-03 | 2010-04-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combination of cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event. |
SG176692A1 (en) | 2009-06-15 | 2012-01-30 | Cardiodx Inc | Determination of coronary artery disease risk. |
-
2010
- 2010-06-15 SG SG2011090107A patent/SG176692A1/en unknown
- 2010-06-15 WO PCT/US2010/038712 patent/WO2010148017A1/en active Application Filing
- 2010-06-15 EA EA201270020A patent/EA201270020A1/ru unknown
- 2010-06-15 KR KR1020127001127A patent/KR20120046171A/ko not_active Application Discontinuation
- 2010-06-15 JP JP2012516212A patent/JP2012529914A/ja active Pending
- 2010-06-15 EP EP10790073.0A patent/EP2443449B1/en not_active Not-in-force
- 2010-06-15 BR BRPI1010693A patent/BRPI1010693A2/pt not_active IP Right Cessation
- 2010-06-15 CA CA2765145A patent/CA2765145A1/en not_active Abandoned
- 2010-06-15 SG SG10201403152QA patent/SG10201403152QA/en unknown
- 2010-06-15 DK DK10790073.0T patent/DK2443449T3/en active
- 2010-06-15 AU AU2010260152A patent/AU2010260152A1/en not_active Abandoned
- 2010-06-15 US US12/816,232 patent/US9122777B2/en not_active Expired - Fee Related
- 2010-06-15 CN CN201080036171XA patent/CN102803951A/zh active Pending
-
2011
- 2011-12-08 IL IL216875A patent/IL216875A0/en unknown
-
2014
- 2014-01-16 US US14/157,196 patent/US8914240B2/en not_active Expired - Fee Related
-
2015
- 2015-07-17 US US14/802,544 patent/US20150315652A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN102803951A (zh) | 2012-11-28 |
US20150315652A1 (en) | 2015-11-05 |
SG176692A1 (en) | 2012-01-30 |
EP2443449B1 (en) | 2017-04-12 |
US20110015865A1 (en) | 2011-01-20 |
US20140156198A1 (en) | 2014-06-05 |
EP2443449A1 (en) | 2012-04-25 |
CA2765145A1 (en) | 2010-12-23 |
JP2012529914A (ja) | 2012-11-29 |
WO2010148017A1 (en) | 2010-12-23 |
DK2443449T3 (en) | 2017-05-15 |
US8914240B2 (en) | 2014-12-16 |
KR20120046171A (ko) | 2012-05-09 |
EP2443449A4 (en) | 2012-12-26 |
US9122777B2 (en) | 2015-09-01 |
IL216875A0 (en) | 2012-02-29 |
AU2010260152A1 (en) | 2012-02-02 |
SG10201403152QA (en) | 2014-08-28 |
EA201270020A1 (ru) | 2012-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1010693A2 (pt) | métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeito | |
BR112012026396A2 (pt) | método de gerenciar um programa de premiação a motorista e um sistema para o mesmo | |
BR112018073172A8 (pt) | Método para a identificação de um tipo de erva daninha, sistema de identificação e produto de programa de computador | |
BR112014001238A2 (pt) | método para a detecção de células cancerosas e/ou classificação de células numa amostra de células de líquido; sistema para a detecção de células e/ou a classificação de células cancerosas numa amostra de células; método de atualização e/ou melhoria de uma base de dados que compreende os limiares ligados á informação holográfica; e base de dados de objetos | |
SG10201907682RA (en) | System and method for providing patient-specific dosing as a function of mathematical models | |
WO2013169178A3 (en) | Social media profiling | |
BR112013018139A8 (pt) | Método para processar dados genômicos de um indivíduo, uso de informação de sequência genômica, opcionalmente na combinação com informação de expressão de gene, apoio à decisão clínica e sistema de armazenamento e sistema | |
EP2827209A3 (en) | System and method for assessing cumulative effects of a failure in an aircraft | |
BR112016013158A2 (pt) | Identificação de candidatos para testes clínicos | |
ATE433124T1 (de) | System und verfahren zum analysieren von radarinformationen | |
BR112014027578A2 (pt) | método em um sistema de processamento de dados para gerar uma linha de base de uso de energia, sistema de processamento de dados configurado para gerar uma linha de base de uso de energia e meio legível por computador não transitório | |
BR112014028332B8 (pt) | Método para fornecer instruções curva-a-curva melhoradas por um dispositivo de navegação pessoal, dispositivo de navegação pessoal e memória legível por computador | |
BR112012006055A2 (pt) | métodos para uso na previsão de produção de areia de um sistema de reservatório geomecânico, para produção de areia de um sistema de reservatório geomecânico, e, para operar um sistema de reservatório geomecânico para controlar produção de areia do sistema de reservatório geomecânico | |
EP2378502A3 (en) | Human reliability assessment tool supporting safety issue analysis and management | |
BR112015006948A2 (pt) | sistema para registrar um sistema de coordenadas de um sistema de detecção de formato, método para registrar um sistema de coordenadas de um sistema de detecção de formato e produto de programa de computador | |
EP2506193A4 (en) | DEMAND PREDICTION DEVICE AND APPLICATION PREDICTION METHOD | |
BR112013017511A2 (pt) | recomendações de interesse em uma facilidade de conselho computacional | |
BR112017003261A2 (pt) | método implementado por computador para estimar um movimento, produto de programa armazenado em um meio legível por computador, e, sistema para estimar um movimento. | |
BR112022004094A2 (pt) | Biomarcadores para predizer atividade de doença de esclerose múltipla | |
BR112013018261A2 (pt) | método para determinação de pelo menos um caminho adequado para o movimento de humano ou tecido animal por meio de um conjunto de dados de intensidade, mídia de leitura por computador, produto de programa de computador e sistema computadorizado | |
BR112012022681A2 (pt) | aparelho e método de processamento de informação, e, meio legível de computador não transitório | |
BR112015005768A2 (pt) | aparelho de análise da atividade uterina; método para renderizar o conteúdo relacionado à atividade uterina de um paciente; e programa de computador armazenado em um meio de memória não transitória legível por computador | |
BR112014028103A2 (pt) | sistema e método para classificação de fácies | |
BR112015005072A2 (pt) | sistema e método de apoio para decisões clínicas; e produto de programa de computador | |
BR112013030122A2 (pt) | método para simular uma resposta de um instrumento de perfilagem de poço de nêutrons, meio legível por computador não transitório, e método para perfilagem de poço |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority |
Free format text: PERDA DAS PRIORIDADES US 61/187,203 DE 15.06.2009 E US 61/245,190 DE 23.09.2009 POIS NAO FOI RESPONDIDA A EXIGENCIA FORMULADA A NA RPI 2518 DE 09/04/2019 SOBRE ESTAS PRIORIDADES REIVINDICADAS. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2534 DE 30-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |